Clinical Trials
Braintumor Website

There are 9 trials:
Facility: Stanford University Medical Center
NCT Trial Name# of Centers

NCT00991029

  Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
210

NCT02484547

  221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
160

NCT01351545

  A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
133

NCT01960075

  Established Status Epilepticus Treatment Trial
49

NCT01677572

  Multiple Dose Study of BIIB037 (Recombinant, Fully Human Anti-A? IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
30

NCT02446587

  Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
9

NCT00883688

  Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
6

NCT00899834

  DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
3

NCT02370563

  PET Imaging of Intracranial Cancers With 18F-FSPG
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites